In this section, we summarize RKIP’s role in immune modulation by examining its interactions with key signaling molecules, its impact on immune cell function, and its regulatory influence on inflammation, particularly in the context of metabolic diseases such as obesity, diabetes, and CVD. This evidence concerns the gene PEBP1 and obesity disorder.